Form 8-K - Current report:
SEC Accession No. 0000950170-25-083044
Filing Date
2025-06-06
Accepted
2025-06-06 16:05:17
Documents
10
Period of Report
2025-06-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K sana-20250605.htm   iXBRL 8-K 68475
  Complete submission text file 0000950170-25-083044.txt   185743

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sana-20250605.xsd EX-101.SCH 31883
12 EXTRACTED XBRL INSTANCE DOCUMENT sana-20250605_htm.xml XML 4892
Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39941 | Film No.: 251030530
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)